Kid Cards: Teaching Kids About Medicines

Neoplasms Clinical Trial

Official title:

Kid Cards: Teaching Kids About Medicines

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT00127543
• Other study ID #: 05 06-089E
• Status: Withdrawn
• Phase: N/A
• Start date: August 2005
• Est. completion date: April 2006

Study information

• Verified date: December 2020
• Source: Children's Mercy Hospital Kansas City
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study is being done to see if education about medicines directed toward children will improve their knowledge. The investigators also want to know if this knowledge lasts over time. Right now there are few medication instructional cards that are appropriate for children. Most of the medication cards provide information for adults. Some studies have shown that by teaching children directly, the children may take medicine at the right time for the right reason, have fewer side effects and know more about their medicine.

The purpose of this research study is to see if education about medication helps children learn more about their medicine and if this knowledge lasts.

Description:

In 2004, then Surgeon General Carmona stated that a health literate individual is more apt to know the answer, when asked how to keep themselves well (AHRQ, 2004). There is a burgeoning movement among medical professionals to address health literacy. Teaching health information to children will empower them to actively participate in their current care and provide self-management skills that will assist them to keep themselves well throughout their lives. Currently, few medication administration instructional cards exist that are appropriate for children. Providing medication information that the child might understand may result in better administration compliance, fewer adverse effects and develop an individual that is knowledgeable regarding medications and appropriate administration. The purpose if this research is to develop medication administration cards, appropriate for children, which provide information on the most commonly used drugs among the Hematology/Oncology population.

The overall objective of this research is to develop medication informational cards for medications frequently used within the Hematology/Oncology pediatric population, and evaluate the effectiveness of these cards, by means of a pre- and post-test.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: April 2006
• Accepts healthy volunteers: No
• Gender: All
• Age group: 7 Years to 11 Years

Eligibility

Inclusion Criteria:

• Between the ages of 7 - 11 years

• Currently receiving disease management primarily coordinated through the Hematology/Oncology section

• Receiving a medication identified as a variable for this study

• Are able to assent and have a parent/guardian who is willing to consent to study participation

• Suffer no apparent developmental difficulty that would prevent or make study participation difficult

Exclusion Criteria:

• Individuals who cannot read or write English

• Individuals who are known to be non-compliant with medication routine and/or adhering to follow-up visits.

Related Conditions & MeSH terms

• Anemia, Sickle Cell
• Blood Coagulation Disorders
• Hemophilia
• Hemostatic Disorders
• Neoplasms
• Sickle Cell Disease

Intervention

Behavioral:
• Medication Education for Children

Locations

Country	Name	City	State
United States	Childrens Mercy Hospitals and Clinics	Kansas City	Missouri

Sponsors (1)

Lead Sponsor	Collaborator
Children's Mercy Hospital Kansas City

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Develop medication cards appropriate for children
Primary	Develop a post-test to determine the effectiveness
Primary	Obtain data to support teaching children about medication
Secondary	Assess the clinical implications of this research